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Abstract
Background: Physiological fatigue can be defined as a reduction in the force output and/or energy-
generating capacity of skeletal muscle after exertion, which may manifest itself as an inability to
continue exercise or usual activities at the same intensity. A typical example of a fatigue-related
disorder is chronic fatigue syndrome (CFS), a disabling condition of unknown etiology and with
uncertain therapeutic options. Recent advances in elucidating pathophysiology of this disorder
revealed hypofunction of the hypothalamic-pituitary-adrenal axis and that fatigue in CFS patients
appears to be associated with reduced motor neurotransmission in the central nervous system
(CNS) and to a smaller extent with increased fatigability of skeletal muscle. There is also some
limited evidence that CFS patients may have excessive serotonergic activity in the brain and low
opioid tone.
Presentation of the hypothesis: This work hypothesizes that repeated cold stress may reduce
fatigue in CFS because brief exposure to cold may transiently reverse some physiological changes
associated with this illness. For example, exposure to cold can activate components of the reticular
activating system such as raphe nuclei and locus ceruleus, which can result in activation of behavior
and increased capacity of the CNS to recruit motoneurons. Cold stress has also been shown to
reduce the level of serotonin in most regions of the brain (except brainstem), which would be
consistent with reduced fatigue according to animal models of exercise-related fatigue. Finally,
exposure to cold increases metabolic rate and transiently activates the hypothalamic-pituitary-
adrenal axis as evidenced by a temporary increase in the plasma levels of adrenocorticotropic
hormone, beta-endorphin and a modest increase in cortisol. The increased opioid tone and high
metabolic rate could diminish fatigue by reducing muscle pain and accelerating recovery of fatigued
muscle, respectively.
Testing the hypothesis: To test the hypothesis, a treatment is proposed that consists of adapted
cold showers (20 degrees Celsius, 3 minutes, preceded by a 5-minute gradual adaptation to make
the procedure more comfortable) used twice daily.
Implications of the hypothesis: If testing supports the proposed hypothesis, this could advance
our understanding of the mechanisms of fatigue in CFS.
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Background
There seems to be no universally accepted definition of
biological fatigue [1], although it is often defined as a
reduction in the force output and/or energy-generating
capacity of skeletal muscle after exertion, which may man-
ifest itself as an inability to continue exercise or usual
activities at the same intensity [1-4]. Fatigue is thought to
be associated with a diminished contractile ability of mus-
cles due to accumulation of lactic acid and depletion of
energy stores (glycogen) [5,6] as well as with a reduction
in motor neurotransmission delivered to skeletal muscle
by the central nervous system (CNS), all of which can
result in diminished force output [7,8]. At the level of the
CNS, precise mechanisms of fatigue are not well under-
stood, although there is some evidence that it may be
associated with diminished activity of a brainstem struc-
ture called reticular activating system [9-11] and with
increased levels of serotonin in the frontal cortex and hip-
pocampus [12,13].
A typical fatigue-related disorder is chronic fatigue syn-
drome (CFS), a complex and disabling condition charac-
terized by extended periods of severe fatigue unexplained
by known medical causes [14]. Currently, there are no
specific diagnostic tests and etiology of CFS remains elu-
sive, although some progress has been made in elucidat-
ing its pathophysiology [15,16]. A number of studies have
reported insufficient function of the hypothalamic-pitui-
tary-adrenal (HPA) axis (e.g. lowered production of corti-
sol [16,17]) and a rather frequent occurrence of
autonomic nervous system dysfunction in patients with
CFS [16,18]. Neither lowered production of cortisol nor
dysautonomia appears to be a causative factor in most
CFS patients because cortisol injections and various ther-
apeutic approaches to autonomic nervous system abnor-
malities have so far shown a rather limited effect on CFS
symptoms [17,19,20]. Other findings about the patho-
physiology of CFS suggest that abnormal fatigability in
this disorder is associated with a reduced ability of the
CNS to recruit motor neurons [21-23] and with some bio-
chemical abnormalities in skeletal muscle [24-26]. In
addition, there is some evidence that CFS patients may
have a low opioid tone ([27-30], contrary evidence:
[31,32]), as well as an increased level of serotonergic activ-
ity in the brain ([33-38], contrary evidence: [39,40]). The
latter has been shown to correlate with fatigue in animal
models of exercise-related fatigue [13,41-45].
This paper describes a physiological treatment, namely,
exposure to moderate cold, which could have a beneficial
effect on some of the above-mentioned pathological
changes as explained in more detail below.
Presentation of the hypothesis
It is known that small amounts of stressful or harmful
agents can be beneficial for animals, a phenomenon
known as hormesis [46,47]. In particular, exposure to
cold can transiently reverse several physiological changes
that are often associated with CFS and therefore, the
hypothesis is that repeated cold stress can reduce fatigue
in CFS patients. The following is detailed theoretical evi-
dence that appears to support this hypothesis.
1) Insufficient function of the HPA axis has been found to
correlate with fatigue [48], for example, a lowered plasma
level of stress hormone cortisol (secreted by adrenal
glands) is one of the few consistent endocrine changes
found in CFS in numerous studies [17], although the level
of cortisol in CFS patients is within the normal range and
therefore cannot be used as a diagnostic tool [16]. Cold
stress is known to transiently activate the HPA axis [49,50]
as evidenced by a brief increase in the plasma levels of
adrenocorticotropic hormone [51,52] and beta-endor-
phin (the latter is a secreted by the pituitary gland)
[53,54], as well as a modest elevation in the level of corti-
sol [55,56]. Some studies reported no significant change
in cortisol levels following cold stress [57,58], which may
be due to gender and diurnal variation of this effect
[55,56]. In addition, there is some evidence of another
deficiency of the HPA axis in various disorders associated
with fatigue: hypofunction of corticotropin-releasing hor-
mone-producing neurons (located in hypothalamus)
[48,59,60]. Therefore, "exercising" the HPA system by
repeated exposure to cold could potentially restore its nor-
mal function in CFS, or at least increase the net HPA activ-
ity (without a change in baseline activity [61]) and,
possibly, reduce fatigue. For example, repeated cold stress
has been shown to enhance HPA axis responsiveness to
other stressors [62,63] and to enhance cortisol responses
to cold stress [64].
2) Cold hydrotherapy is known to produce a significant
analgesic effect [65-67], which could be beneficial in CFS,
where pain symptoms are rather common [68,69]. The
cold stress-induced analgesia is believed to be mediated
by increased production of opioid peptide beta-endor-
phin, which is an endogenous pain-killer [53,55,70,71].
3) Exposure to cold is known to increase metabolic rate:
for instance, head-out immersion in cold water of 20°C
almost doubles metabolic rate, while at 14°C it is more
than quadrupled [72]. Theoretically, the high metabolic
rate may accelerate [73,74] the process of recovery of mus-
cle tissues from fatigue in CFS [24,25,75,76] and some
studies indeed show accelerated muscle recovery follow-
ing immersion in cold water [77,78]. In combination with
cold-induced analgesia described above, the increased
metabolic rate would be expected to reduce fatigue by
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both improving muscle recovery after exertion and by
reducing muscle pain [79]. A cold-induced increase in cer-
ebral metabolic rate [80] may also be consistent with
reduced fatigue ([7,81] contrary evidence: [82,83]).
4) There is evidence that exposure to cold can activate
some components of the brainstem arousal system [84-
86] (also known as the reticular activating system
[87,88]). In particular, cold stress appears to stimulate
activity of serotonergic neurons of raphe nuclei [84,89-
91] and noradrenergic neurons of locus ceruleus [84,92],
the situation that would be consistent with activation of
behavior and enhanced somatomotor function of the
brain [9,87,93-96]. This could be beneficial in CFS
because abnormally high fatigability of CFS patients
appears to be mediated by a reduction in the ability of the
CNS to generate motor neurotransmission [21-23]. It is
noteworthy that in polio survivors and patients with mul-
tiple sclerosis, the presence of minor lesions in the reticu-
lar activating system correlates with severe chronic fatigue
[10,97]. This kind of lesions can also cause lethargy in lab-
oratory animals [9,88,98]. Reduced electrical activity in
the reticular activating system also appears to correlate
with fatigue in laboratory animals [99-101]. At present,
there is no evidence that CFS patients have lesions in the
reticular activating system [9,102], although there is some
limited evidence of abnormalities of metabolism, blood
flow, and electrical activity in the brainstem [81,103-105],
the anatomical site of the reticular activating system
[87,88].
5) While the increased level of serotonin in the brainstem
[85] is thought to correlate with arousal and increased cor-
tical activity [11,94,106], high levels of serotonin in other
areas of the brain, particularly in the hippocampus and
frontal cortex, are believed to be associated with fatigue,
which is the basis of "the serotonin hypothesis of central
fatigue" [12,13,41-45]. Whether high levels of brain sero-
tonin actually cause fatigue or are merely an epiphenom-
enon is a subject of controversy [12,13]. With respect to
cold stress, studies suggest that it reduces the level of sero-
tonin in most regions of the brain [107,108] except the
rostral brainstem [85], which would be consistent with
diminished fatigue [12,13] and could be beneficial in CFS
([33-38], contrary evidence: [39,40]).
6) Exposure to cold typically causes activation of the sym-
pathetic nervous system (SNS) [49,109], which, theoreti-
cally, can be undesirable in CFS because there is evidence
of hyperactivity of some components of the SNS in CFS
patients [18,110]. It should be noted that physical exercise
is also known to transiently activate the SNS [111] and
graded exercise appears to be beneficial in CFS [112,113].
Therefore, brief cold stress will not necessarily have
adverse effects on CFS patients (more detailed discussion
can be found in Additional file 1).
7) As described previously, brief cold hydrotherapy
appears to be safe and does not seem to have either short-
term or long-term adverse effects on health [109,114-
117]. The effect of moderately cold hydrotherapy (16–
23°C) on core body temperature is expected to be very
small and therefore hypothermia is hardly a concern
[118-120].
Testing the hypothesis
To test the hypothesis, a treatment is proposed that con-
sists of adapted cold showers (20°C, 3 minutes, preceded
by 5-minute gradual adaptation) twice a day. The detailed
study protocol can be found in Additional file 2. Statisti-
cally insignificant preliminary evidence is described in
Additional file 3.
Implications of the hypothesis
If statistically significant studies confirm (or refute) the
hypothesis, this could further our understanding of the
mechanisms of physiological fatigue and possibly con-
tribute to the development of new therapeutic approaches
to CFS.
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